Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2026 | Diagonal Therapeutics | $125.0M Series B | Janus Henderson Investors, Paulina Hill | Atlas Venture, Balyasny Asset Management, BVF Partners, Checkpoint Capital, Deep Track Capital, EcoR1 Capital, Frazier Life Sciences, Lightspeed Venture Partners, Logos Capital, RA Capital Management, RV Invest, Velosity Capital, Viking Global Investors |
| May 1, 2024 | Radar Therapeutics | $13.0M Seed | Omri Amirav-Drory | Angelic Ventures, Arizona Tech Investors, B Capital Group, Endeavor Venture Funds, ExSight Capital Management, IVP, NFX, Pioneer Fund, Prithvi Ventures, Chris Gibson, BEVC, Eli Lilly and Company, KdT Ventures, Pear VC |
| Jun 23, 2022 | Elucid | $27.0M Series B | — | BlueStone Venture Partners, Bold Brain Ventures, IAG Capital Partners, John Fichthorn |